Clinical Trials
86 trialsUNC-CAYACC
UNC Lineberger Comprehensive Cancer Center
Prospective Validation of a Points Score System Predicting 30-day Survival
Indiana University
UNC Metastatic Cancer Radiation Therapy Registry
UNC Lineberger Comprehensive Cancer Center
ESOP
Assistance Publique - Hôpitaux de Paris
Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
M.D. Anderson Cancer Center
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
National Cancer Institute (NCI)
PROMPT
University Health Network, Toronto
MTRON
AO Innovation Translation Center
YRENE
Instituto de Investigacion Sanitaria La Fe
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Duke University
PORTENT
Casa Sollievo della Sofferenza IRCCS
QUEPAL
Institut Curie
NTRK
Institut Bergonié
Biomarkers of Immune-Related Toxicity
University of Colorado, Denver
BMD
Istituto Ortopedico Rizzoli
CRANIUM
Center Eugene Marquis
GS_ZKM
Gene Solutions
PRISMM
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
EDPO
Indiana University
InterOncoRea
University Hospital, Brest
KOSMOSII
Seoul National University Bundang Hospital
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
Mayo Clinic
AUTENTIC
Hospital Universitario Araba
FAPI PET/CT in Various FAP-Related Disease Patients
Tianjin Medical University
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
Tianjin Medical University
LAROTRACKING
Centre Leon Berard
TScoreBTR
Clinica Universidad de Navarra, Universidad de Navarra
BESACE
Assistance Publique - Hôpitaux de Paris
HDM-PMP22
Centro Nacional de Investigaciones Oncologicas CARLOS III
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
University Hospital, Basel, Switzerland
DigiSTEPS
Cedars-Sinai Medical Center
IRMO
Fondazione IRCCS Policlinico San Matteo di Pavia
IRIS
University Health Network, Toronto
Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model
Fudan University
Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty
Podkarpackie Oncological Center
ALPS
University Hospital Augsburg
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
Assiut University
Comparison Between LDCT With DL Recontruction and Standard Dose CT
Seoul National University Hospital
PROCC
Wake Forest University Health Sciences
ATLANT
Blokhin's Russian Cancer Research Center
ST-ICI
University of Erlangen-Nürnberg Medical School
ES4-UIC
Institut Curie
PRaG 2X
Second Affiliated Hospital of Soochow University
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
Samsung Medical Center
Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer
Samsung Medical Center
Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
University of Rochester
FAST-METS
Amsterdam UMC, location VUmc
MAVERRIC
Karolinska Institutet
SEEDLING
University Hospital Heidelberg